Loyalty Program Comparison: Allē vs Aspire vs Evolus Rewards

Allē is Allergan Aesthetics' direct-to-consumer and provider program. Patients earn points on eligible purchases (Botox, Juvederm, Volbella, Skinvive, and other Allergan injectables); providers can also enroll to offer patient incentives. Points typically convert to discounts or free treatments after a threshold is met. The program is free to join and integrates with Allergan's digital ecosystem. Key mechanics:

• Points accumulate per unit or dollar spent, depending on product tier
• Redemption thresholds vary; some practices report breakeven at 3–5 treatments per patient per year
• Allē integrates with patient CRM platforms, making tracking seamless
• No direct rebate to the practice; value flows to patients, driving retention and repeat visits

For practices, Allē's real benefit is patient stickiness—patients who enroll are statistically more likely to return. The program does not reduce your cost of goods; it reduces patient friction at checkout.

Aspire (Galderma's program) operates on a tiered, volume-based model targeting both providers and patients. Providers earn rebates or credits based on annual spend thresholds on Restylane, Dysport, and other Galderma products. Patient-facing rewards are also available. Key differences from Allē:

• Provider rebates: Typically structured as tiered discounts or account credits once annual volume targets are met (e.g., 5%, 8%, or 10% rebates at certain spend levels)
• Quarterly or annual reconciliation: Rebates are not real-time; you must track and reconcile with Galderma
• Product-specific tiers: Different rebate rates for different product lines (neuromodulators vs. fillers)
• Requires enrollment and documentation: You must register, maintain records, and submit proof of purchase

Aspire's value is direct cost reduction, but only if you hit volume thresholds. For low-volume practices or those with mixed product portfolios, the rebate may not justify the administrative overhead.

Evolus Rewards is Evolus Inc.'s loyalty program, centered on their neuromodulator Jeuveau and filler RHA Collection (including the recently FDA-approved RHA Dynamic Volume for midface augmentation). The program is newer and less widely adopted than Allē or Aspire, but offers:

• Direct provider incentives: Rebates or volume bonuses tied to Jeuveau and RHA purchases
• Tiered structure: Higher rebates as annual spend increases
• Flexible redemption: Credits can often be applied to future inventory purchases or account balances
• Smaller installed base: Fewer patients are familiar with Evolus products, which can limit program value if your patient base is Botox/Juvederm-centric

Evolus Rewards is most valuable for practices already committed to Jeuveau or RHA as core products. For mixed portfolios, the rebate alone may not justify shifting volume away from market-leading brands.

Direct stacking of these three programs is not possible. Each program is brand-specific:

• Allē rewards only Allergan Aesthetics products (Botox, Juvederm, Skinvive, Volbella, Kybella, etc.)
• Aspire rewards only Galderma products (Restylane, Dysport, Radiesse, etc.)
• Evolus Rewards rewards only Evolus products (Jeuveau, RHA Collection)

However, you can layer programs across your practice portfolio:

• Enroll patients in Allē for Allergan treatments
• Enroll patients in Aspire for Galderma treatments
• Offer Evolus Rewards for Jeuveau/RHA patients
• Each program operates independently; patients accumulate rewards within their respective ecosystem

The real stacking opportunity is multi-brand practice strategy: by offering all three brands and educating patients about each program, you maximize patient lifetime value and reduce churn. The trade-off is inventory complexity and staff training.

Program value depends on three variables: patient volume, product mix, and rebate structure. To assess ROI:

1. Estimate annual spend per brand (units × average cost per unit)
2. Check current rebate tiers with each manufacturer—contact Allergan Aesthetics, Galderma, and Evolus directly for current thresholds and rates; these change quarterly
3. Calculate breakeven: If Aspire offers 8% rebate at $50k annual spend, that's $4,000/year—meaningful only if you're already at that volume
4. Compare to patient acquisition cost: If Allē retention saves you $2,000/year in lost patients, that's your real ROI
5. Factor in administrative burden: Tracking, reconciliation, and staff time to manage multiple programs has a cost

For most independent practices, Allē (patient-facing) is easiest to implement because it requires no rebate reconciliation. Aspire and Evolus Rewards are worth pursuing only if you're already a high-volume user of those brands or if you're actively building a multi-brand strategy.

Manufacturer programs evolve frequently. Recent developments:

• Allergan Aesthetics (AbbVie) recently expanded Allē to include Skinvive by Juvederm (FDA-approved for neck lines and appearance improvement), broadening the product portfolio and patient appeal
• Galderma expanded Restylane offerings with Restylane Contour (FDA-approved for temple hollowing), which may affect Aspire rebate structures
• Evolus launched RHA Dynamic Volume (FDA-approved for midface augmentation and age-related volume loss), expanding Evolus Rewards eligibility

What to check quarterly:

• Contact each manufacturer's provider relations team for current rebate rates and thresholds
• Review your practice's annual spend to confirm you're in the right tier
• Ask about seasonal promotions or limited-time rebate boosts
• Confirm which new products are eligible for each program

Program terms are not published uniformly; you must request them directly from Allergan Aesthetics, Galderma, and Evolus.

Allē is the easiest win for patient retention; Aspire and Evolus Rewards are worth pursuing only if you're already high-volume or building a deliberate multi-brand strategy. Real value comes from stacking programs across brands, not within them. Track your annual spend, confirm rebate tiers directly with manufacturers, and prioritize the program that aligns with your core product mix and patient base.